| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |
| mRNA |
Roscovitine |
GDSC1000 |
pan-cancer |
AAC |
-0.0078 |
0.9 |
| mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.9 |
| mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |